Prevention and Management of Hepatitis B in Healthcare Professionals

被引：6

作者：

O’Brien C.R. ^{[1
]}

Lim J.K. ^{[2
]}

机构：

[1] Department of Internal Medicine, Yale University School of Medicine, 333 Cedar Street, LMP 1080, New Haven, 06520-8019, CT

[2] Yale Liver Center and Section of Digestive Diseases, Yale University School of Medicine, New Haven, CT

来源：

Current Hepatology Reports | 2019年 / 18卷 / 1期

关键词：

Healthcare professionals; Hepatitis B; Needlestick injury; Occupational health; Vaccination;

D O I：

10.1007/s11901-019-00444-6

中图分类号：

学科分类号：

摘要：

Purpose of Review: To review the epidemiology of hepatitis B virus (HBV) transmission in the healthcare setting and outline best practices in the prevention and management of chronic HBV in healthcare professionals. Recent Findings: Hepatitis B virus (HBV) infection remains a global public health burden and chronically infects an estimated 257 million persons worldwide. HBV represents one of the most important occupational risks for healthcare workers (HCWs) due to efficient transmission through percutaneous exposure of HBV-infected blood and blood-contaminated body fluids. Although the incidence of HCW-patient transmission of HBV has decreased significantly since 2000, ongoing deficits in HCW testing, vaccination, and confirmation of immunity, as well as post-exposure management protocols, raise concern for ongoing risk for nosocomial exposure. Summary: Established recommendations of the AASLD, CDC, and SHEA provide guidance to clinicians on the prevention and management of chronic HBV in healthcare professionals. © Springer Science+Business Media, LLC, part of Springer Nature 2019.

引用

页码：1 / 8

页数：7

共 44 条

[1]

Global Hepatitis Report 2017, (2017)

[2]

Chang M.S., Nguyen M.H., Epidemiology of hepatitis B and the role of vaccination, Best Pract Res Clin Gastroenterol, 31, pp. 239-247, (2017)

[3]

Schillie S., Vellozzi C., Reingold A., Et al., Prevention of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices, MMWR Recomm Rep, 67, pp. 1-31, (2018)

[4]

Weinbaum C.M., Williams I., Mast E.E., Wang S.A., Finelli L., Wasley A., Recommendations for identification and public health management of persons with chronic hepatitis B infection, MMWR Recomm Rep, 57, RR08, pp. 1-20, (2008)

[5]

Dienstag J., Hepatitis B virus infection, NEJM, 359, pp. 1486-1500, (2008)

[6]

Van der Eijk A., Et al., Hepatitis B virus (HBV) DNA levels and the management of HBV-infected health care workers, J Viral Hepat, 13, pp. 2-4, (2006)

[7]

Nguyen M.H., Lim J.K., Ozbay A.B., Fraysse J., Liou I., Meyer N., Advancing age and comorbidity in a United States insured population-based cohort of patients with chronic hepatitis B, Hepatology, (2018)

[8]

Centers for Disease Control and Prevention., (2016)

[9]

Hasak J.M., Novak C.B., Patterson J.M., Mackinnon S.E., Prevalence of needlestick injuries, attitude changes, and prevention practices over 12 years in an urban academic hospital surgery department, Ann Surg, 267, pp. 291-296, (2018)

[10]

Nguyen M.H., Ozbay A.B., Liou I., Meyer N., Gordon S.C., Dusheiko G., Healthcare resource utilization and costs by disease severity in an insured national sample of US patients with chronic hepatitis B, J Hepatol, 70, pp. 24-32, (2019)

← 1 2 3 4 5 →